A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Biofilm Derived Oxylipin Mediated Autoimmune Response in Breast Implant Subjects
[article]
2020
medRxiv
pre-print
AbstractOver 10 million women worldwide have breast implants for breast cancer/prophylactic reconstruction or cosmetic augmentation. In recent years, a number of patients have described a constellation of symptoms that are believed to be related to their breast implants. This constellation of symptoms has been named Breast Implant Illness (BII). The symptoms described include chronic fatigue, joint pain, muscle pain and a host of other manifestations often associated with autoimmune illnesses.
doi:10.1101/2020.11.18.20233510
fatcat:vtk2pfvjhjhntnijdsccmosnwu